122 related articles for article (PubMed ID: 7485107)
1. Lymphoid malignancies following Kawasaki disease.
Murray JC; Bomgaars LR; Carcamo B; Mahoney DH
Am J Hematol; 1995 Dec; 50(4):299-300. PubMed ID: 7485107
[TBL] [Abstract][Full Text] [Related]
2. Neoplasms in three patients following Kawasaki disease.
Suzuki H; Takeuchi T; Minami T; Shima Y; Iwahashi S; Shibuta S; Uemura S; Kounami S; Aoyagi N; Yoshikawa N
Pediatr Int; 2005 Apr; 47(2):217-9. PubMed ID: 15852529
[No Abstract] [Full Text] [Related]
3. [Regulation system of apoptosis contributes to the human pro-B leukemogenesis].
Inaba T
Rinsho Ketsueki; 1998 Feb; 39(2):95-7. PubMed ID: 9545808
[No Abstract] [Full Text] [Related]
4. Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia.
Cui L; Li Z; Wu M; Li W; Gao C; Deng G
Leuk Res; 2010 Oct; 34(10):1314-9. PubMed ID: 20034668
[TBL] [Abstract][Full Text] [Related]
5. Acute Lymphoblastic Leukemia Presenting With Pancytopenia Followed by a 14-Month-Long Period of Transient Remission Possibly Supporting the Adrenal Hypothesis of Leukemogenesis.
Lynggaard LS; Marquart HV; Kjeldsen E; Madsen HO; Hasle H
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e271-e273. PubMed ID: 27509378
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
7. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
[No Abstract] [Full Text] [Related]
8. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
9. An uncommon overlap of two common rheumatological disorders.
Guleria S; Jindal A; Pilania R; Bhattarai D; Kaur A; Naganur S; Pandiarajan V; Suri D; Singh S
Lupus; 2020 Aug; 29(9):1121-1125. PubMed ID: 32515654
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease in a child with acute lymphoblastic leukemia.
Kim HS; Roh HO; Kang SH; Lyu CJ; Kim KY; Hong SW; Yang WI
Yonsei Med J; 1991 Sep; 32(3):270-4. PubMed ID: 1781187
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
12. [Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms].
Caballero-Mora FJ; Alonso-Martín B; Tamariz-Martel-Moreno A; Cano-Fernández J; Sánchez-Bayle M
An Pediatr (Barc); 2011 Apr; 74(4):232-8. PubMed ID: 21296631
[TBL] [Abstract][Full Text] [Related]
13. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
14. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
Landmann E; Burkhardt B; Zimmermann M; Meyer U; Woessmann W; Klapper W; Wrobel G; Rosolen A; Pillon M; Escherich G; Attarbaschi A; Beishuizen A; Mellgren K; Wynn R; Ratei R; Plesa A; Schrappe M; Reiter A; Bergeron C; Patte C; Bertrand Y
Haematologica; 2017 Dec; 102(12):2086-2096. PubMed ID: 28983060
[TBL] [Abstract][Full Text] [Related]
15. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):376-81. PubMed ID: 22932404
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin lymphoma as second malignancy during continuing chemotherapy for childhood acute lymphoblastic leukemia.
Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
Klin Padiatr; 2008; 220(6):388-90. PubMed ID: 18949677
[TBL] [Abstract][Full Text] [Related]
18. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
[TBL] [Abstract][Full Text] [Related]
20. Kawasaki disease: infection, immunity and genetics.
Wang CL; Wu YT; Liu CA; Kuo HC; Yang KD
Pediatr Infect Dis J; 2005 Nov; 24(11):998-1004. PubMed ID: 16282937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
